BFC Planning’s Disc Medicine IRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$458 Hold
7
– – ﹤0.01% 3298
2026
Q2
$512 Hold
7
– – ﹤0.01% 3251
2026
Q1
$448 Hold
7
– – ﹤0.01% 2869
2025
Q4
$556 Hold
7
– – ﹤0.01% 2910
2025
Q3
$463 Buy
+7
New +$416 ﹤0.01% 2764

Other funds holding IRON

BFC Planning's IRON Position: Q3 2026 in Review

BFC Planning held its Disc Medicine (IRON) position steady in Q3 2026 at 7 shares worth $458. The position accounts for ﹤0.01% of the portfolio, ranked #3298.

BFC Planning first reported a position in IRON in Q3 2025 and has held it in 5 quarters since. The position peaked at $556 in Q4 2025. 150 funds tracked by Wall St. Rank hold IRON as of Q3 2026.

  • BFC Planning held 7 shares of Disc Medicine worth $458 as of Q3 2026.
  • BFC Planning left its Disc Medicine share count unchanged in Q3 2026.
  • Disc Medicine made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3298 holding.
  • BFC Planning first reported a position in Disc Medicine in Q3 2025 and has held it in 5 quarters since.
  • BFC Planning's Disc Medicine position peaked at $556 in Q4 2025.
  • 150 funds tracked by Wall St. Rank held Disc Medicine as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.